Can J Surg. 2019 Oct 1;62(5):358-360. doi: 10.1503/cjs.009018.
The management of high-risk benign breast disease (BBD) is changing because of improvements in radiological and pathological analysis. We sought to determine the current practice recommendations of breast health professionals in managing patients with high-risk BBD. We surveyed members of the Canadian Society of Surgical Oncology, Canadian Association of General Surgeons and Canadian Association of Radiologists. The survey contained demographic and case-based questions concerning management of high-risk benign breast lesions. Participants were asked for their recommendations and opinions regarding future risk of breast cancer as well as the role of chemoprevention. There was no consistency among the 41 respondents in the treatment recommendations for any of the high-risk benign conditions, and the lifetime risk associated with classic lobular carcinoma in situ was vastly underestimated. Education and evidenced-based guidelines are urgently needed to ensure more uniform practice nationally.
由于放射学和病理学分析的改进，高危良性乳腺疾病 (BBD) 的管理正在发生变化。我们旨在确定乳腺健康专业人员管理高危 BBD 患者的当前实践建议。我们对加拿大外科肿瘤学会、加拿大普通外科医生协会和加拿大放射学家协会的成员进行了调查。该调查包含有关高危良性乳腺病变管理的人口统计学和基于病例的问题。参与者被要求就乳腺癌的未来风险以及化学预防的作用提出建议和意见。在任何一种高危良性疾病的治疗建议方面，41 名受访者之间没有一致性，并且经典小叶原位癌的终生风险被大大低估。迫切需要教育和循证指南，以确保在全国范围内更统一的实践。
